Gian Life Care Limited

BSE: GIANLIFE542918ISIN INE063601012

Healthcare
Healthcare Service Provider

Share price

₹4.25-0.03 (-0.70%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹13.23
52W low: ₹3.93
Off 52W high: -67.88%
1M return: -9.38%
3M return: -13.44%
6M return: -26.09%
1Y return: -65.05%
20D avg volume: 3,715
50 DMA: ₹4.57
200 DMA: ₹6.14

Key ratios Consolidated

Market cap: ₹4.40 Cr
Current price: ₹4.25
52W high / low: ₹13.23 / ₹3.93
Face value: ₹10.00
P/E: 0.00
P/B: 0.23
EPS (TTM): ₹0.00
Book value / share: ₹18.15
ROE: —
ROCE: 2.40%
Operating margin: —
Net margin: —
Debt / equity: 0.30
Net debt: ₹-1.11 Cr
Interest cover: 1.08
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 164.1 days

Financials

Metric	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24
Income statement
	1.12	0.66	0.87	1.11	1.59	1.95	1.98	4.60	3.79	2.30	2.43
	0.09	0.09	0.15	0.24	0.16	0.17	0.18	0.18	0.19	0.15	0.14
	1.21	0.75	1.02	0.87	1.75	2.11	2.17	4.79	3.98	2.45	2.57
	1.13	1.30	0.94	1.52	1.36	1.97	2.02	1.77	1.90	2.21	2.17
	0.27	0.30	0.11	0.26	0.05	0.49	0.40	0.20	0.27	0.61	0.68
	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	0.10	0.10	0.12	0.15	0.14	0.15	0.15	0.26	0.28	0.20	0.22
	0.15	0.12	0.09	0.13	0.12	0.12	0.14	0.10	0.14	0.11	0.12
	0.11	0.11	0.11	0.27	0.12	0.12	0.12	0.11	0.16	0.13	0.13
	0.50	0.66	0.50	0.71	0.92	1.08	1.21	1.10	1.05	1.16	1.02
	0.08	-0.55	0.08	-0.65	0.39	0.14	0.15	3.02	2.08	0.24	0.40
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.08	-0.55	0.08	-0.65	0.39	0.14	0.15	3.02	2.08	0.24	0.40
	0.03	-0.04	0.03	0.05	0.04	0.03	0.06	0.89	0.53	0.04	0.14
	0.10	-0.51	0.05	-0.60	0.35	0.12	0.09	2.13	1.55	0.20	0.26
	0.10	-0.50	0.05	-0.59	0.34	0.12	0.09	2.07	1.50	0.20	0.25
Key metrics
	0.34	-0.32	0.28	-0.25	0.63	0.38	0.41	3.23	2.38	0.48	0.65
	30.40%	-48.50%	32.20%	-22.50%	39.60%	19.50%	20.70%	70.20%	62.80%	20.90%	26.70%
	8.90%	-77.30%	5.70%	-54.10%	22.00%	6.20%	4.50%	46.30%	40.90%	8.70%	10.70%
	—	-1.90%	—	-2.20%	—	—	—	—	—	—	—
	-29.60%	-66.20%	-56.10%	-75.90%	-58.00%	-15.20%	-18.50%	—	—	—	—
	-71.40%	-525.00%	-44.40%	-128.20%	-77.40%	-40.00%	-65.40%	—	—	—	—

Metric	TTM	FY25	FY24
Income statement
	3.76	6.63	13.12
	0.57	0.27	0.67
	3.85	6.90	13.79
	4.89	6.86	8.04
	0.94	1.20	1.76
	0.00	0.00	—
	0.47	0.59	0.96
	0.49	0.51	0.46
	0.60	0.63	0.53
	2.37	3.92	4.33
	-1.04	0.04	5.75
	0.00	0.00	0.00
	-1.04	0.04	5.75
	0.07	0.08	1.59
	-0.96	-0.04	4.15
	-0.94	-0.04	4.02
Key metrics
	0.05	1.18	6.74
	1.33%	17.80%	51.40%
	-25.53%	-0.60%	31.60%
	—	2.40%	—
	-62.85%	-49.50%	—
	-135.69%	-101.00%	—
	—	0.27	—
	—	-6.75	—
	—	0.30	—
	—	-1.11	—
	—	164.1	—
Balance sheet
	—	35.93	—
	—	18.33	—
	—	6.96	—
	—	6.09	—
	—	0.62	—
	—	4.66	—
	—	4.45	—
	—	3.73	—
	—	12.60	—
	—	5.85	—
	—	2.76	—
	—	3.09	—
	—	19.23	—
Cash flow
	—	0.27	—
	—	0.25	—
	—	0.45	—
	—	0.00	—

Metric	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24
Income statement
	1.12	0.66	0.87	1.11	1.59	1.95	1.98	4.60	3.79	2.30	2.43
	0.09	0.09	0.15	-0.24	0.16	0.16	0.17	0.18	0.16	0.15	0.14
	1.21	0.75	1.02	0.87	1.75	2.11	2.15	4.79	3.95	2.45	2.57
	1.12	1.25	0.94	1.33	1.32	1.94	1.99	1.68	1.79	2.21	2.17
	0.27	0.30	0.11	0.26	0.05	0.49	0.40	0.20	0.27	0.61	0.68
	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	0.10	0.10	0.12	0.15	0.14	0.15	0.16	0.26	0.23	0.20	0.22
	0.13	0.09	0.09	0.10	0.10	0.10	0.11	0.11	0.11	0.11	0.12
	0.11	0.11	0.11	0.11	0.12	0.12	0.12	0.07	0.13	0.13	0.13
	0.49	0.64	0.50	0.70	0.92	1.08	1.21	1.04	1.05	1.16	1.02
	0.10	-0.50	0.08	-0.46	0.42	0.17	0.17	3.11	2.16	0.24	0.40
	0.00	0.00	0.00	0.00	—	—	—	—	—	—	—
	0.10	-0.50	0.08	-0.46	0.42	0.17	0.17	3.11	2.16	0.24	0.40
	-0.03	0.04	0.03	0.02	0.04	0.03	0.06	0.91	0.53	0.04	0.14
	0.12	-0.46	0.06	-0.48	0.39	0.14	0.11	2.20	1.63	0.20	0.27
	0.12	-0.45	0.05	-0.47	0.37	0.14	0.10	2.13	1.57	0.20	0.26
Key metrics
	0.34	-0.30	0.28	-0.25	0.64	0.39	0.40	3.29	2.40	0.48	0.65
	30.40%	-45.50%	32.20%	-22.50%	40.30%	20.00%	20.20%	71.50%	63.30%	20.90%	26.70%
	10.70%	-69.70%	6.90%	-43.20%	24.50%	7.20%	5.60%	47.80%	43.00%	8.70%	11.10%
	—	-1.80%	—	-1.50%	—	—	—	—	—	—	—
	-29.60%	-66.20%	-56.10%	-75.90%	-58.00%	-15.20%	-18.50%	—	—	—	—
	-69.20%	-428.60%	-45.50%	-121.80%	-76.10%	-30.00%	-59.30%	—	—	—	—

Metric	TTM	FY25	FY24
Income statement
	3.76	6.63	13.12
	0.09	0.25	0.64
	3.85	6.88	13.76
	4.64	6.58	7.85
	0.94	1.20	1.76
	0.00	0.00	—
	0.47	0.59	0.91
	0.41	0.41	0.45
	0.44	0.47	0.46
	2.33	3.90	4.27
	-0.78	0.30	5.91
	0.00	0.00	—
	-0.78	0.30	5.91
	0.06	0.14	1.62
	-0.76	0.16	4.30
	-0.75	0.14	4.16
Key metrics
	0.07	1.18	6.82
	1.86%	17.80%	52.00%
	-20.21%	2.40%	32.80%
	—	3.00%	—
	-62.85%	-49.50%	—
	-126.76%	-96.30%	—
	—	0.25	—
	—	1.56	—
	—	0.26	—
	—	-1.88	—
	—	174.0	—
Balance sheet
	—	35.55	—
	—	18.32	—
	—	6.95	—
	—	6.09	—
	—	0.62	—
	—	4.66	—
	—	4.00	—
	—	3.55	—
	—	12.13	—
	—	5.07	—
	—	2.50	—
	—	2.57	—
	—	19.76	—
Cash flow
	—	0.25	—
	—	0.23	—
	—	0.49	—
	—	0.00	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -62.85%
Profit YoY (TTM): -126.76%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -62.85%
Profit YoY (TTM): -135.69%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Dr. Lal Pathlabs Limited	34,056	2,028.95	57.92	25.70%	+16.71% TTM	+8.93% TTM	+28.73%
Vijaya Diagnostic Centre Limited	14,676	1,424.85	72.05	19.20%	+24.48% TTM	+33.96% TTM	+39.02%
Metropolis Healthcare Limited	12,075	582.05	53.57	15.70%	+19.84% TTM	+41.90% TTM	+14.58%
Thyrocare Technologies Limited	7,883	495.25	55.01	33.60%	+21.99% TTM	+13.16% TTM	+9.41%
Nephrocare Health Services Limited	6,242	620.75	48.72	13.70%	—	—	—
SURAKSHA DIAGNOSTIC LIMITED	1,735	333.10	49.46	14.70%	+23.32% TTM	+7.94% TTM	+2.54%
Krsnaa Diagnostics Limited	1,566	482.90	15.97	10.60%	+15.90% TTM	+16.02% TTM	-37.25%
3B BlackBio Dx Limited	1,142	1,330.25	20.29	22.60%	+54.30% TTM	+14.75% TTM	-1.52%
HEALTH X PLATFORM LIMITED	863	271.20	-33.11	—	+28.85% TTM	+82.45% TTM	-8.73%
ONE GLOBAL SERVICE PROVIDER LIMITED S	861	440.70	11.65	65.70%	+161.55% TTM	+178.28% TTM	+21.17%
Gaudium IVF and Women Health Limited	779	107.05	—	23.10%	—	—	—
Aspira Pathlab & Diagnostics Limited S	144	140.35	-318.98	2.90%	+14.50% TTM	-117.58% TTM	+132.68%
Choksi Laboratories Ltd. S	142	203.90	65.77	12.30%	+10.74% TTM	+44.00% TTM	+38.05%
STAR IMAGING AND PATH LAB LIMITED	120	68.90	—	22.60%	—	—	-51.78%
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED S	86	57.00	—	11.20%	—	—	—
Sharma East India Hospitals And Res S	34	87.05	24.11	14.20%	+14.13% TTM	-9.85% TTM	-38.28%
BANDARAM PHARMA PACKTECH LIMITED	34	19.03	25.81	4.70%	+114.59% TTM	+454.17% TTM	-22.14%
N.G.Industries Ltd. S	34	100.00	17.39	6.30%	+2.18% TTM	-74.06% TTM	-23.28%
Deccan Health Care Limited	29	12.00	11.40	3.20%	-0.37% TTM	+145.63% TTM	-29.41%
Chennai Meenakshi Multispeciality Hospital Ltd. S	27	36.78	-32.26	-2.80%	+0.08% TTM	+6.59% TTM	-29.27%
SAMSRITA LABS LIMITED	27	11.93	-3.33	-73.40%	—	—	-43.35%
Tejnaksh Healthcare Limited	26	12.83	21.19	5.90%	-12.97% TTM	-33.15% TTM	-27.02%
Transgene Biotek Ltd.	17	2.57	-12.11	-0.50%	-14.81% TTM	-23.85% TTM	-28.21%
Dolphin Medical Services Ltd. S	11	7.11	59.25	0.60%	-1.25% TTM	+700.00% TTM	+246.83%
Looks Health Services Limited S	11	10.08	504.00	0.20%	-41.89% TTM	-57.14% TTM	+101.20%
Gian Life Care Limited	4	4.25	—	2.40%	-62.85% TTM	-135.69% TTM	-65.05%

Filings & corporate actions

Recent announcements

Please find attached herewith Certificate under regulation 74(5) for the Quarter ended March 31, 2026. For Gian Life Care Limited21 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir/Maam, The Company has entered into Hospital lab Management Services Agreement with M/s. Brahma Hospital (HUF). Detailed intimation is attached. Regards Gian Life Care Limited4 Mar 2026 · Company Update / General
Quarterly Results December 202514 Feb 2026 · Result / Financial Results
Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....14 Feb 2026 · Board Meeting / Outcome of Board Meeting
Gian Life Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve As per the captioned subject, ....9 Feb 2026 · Board Meeting / Board Meeting
Dear Sir/ Maam, Please find attached herewith Unaudited Standalone and Consolidated Financial Results for the quarter/ half year ended September 30, 2025. Kindly take the same on ....28 Jan 2026 · Result / Financial Results
Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....28 Jan 2026 · Board Meeting / Outcome of Board Meeting
Gian Life Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve As per the captioned subject, ....24 Jan 2026 · Company Update / Board Meeting Rescheduled
Gian Life Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2026 ,inter alia, to consider and approve As per the captioned subject, ....21 Jan 2026 · Company Update / Board Meeting Rescheduled
Please find attached herewith Certificate under regulation 74(5) for the Quarter ended December 31, 2025.21 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Gian Life Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 ,inter alia, to consider and approve As per the captioned subject, ....15 Jan 2026 · Board Meeting / Board Meeting
Reg 74(5) Certificate September 202518 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached herewith Voting Results and Scrutinisers Report.6 Oct 2025 · AGM/EGM / AGM
Please find attached herewith proceedings of AGM4 Oct 2025 · AGM/EGM / AGM
Please find attached herewith proceedings of AGM4 Oct 2025 · Company Update / General
Please find attached herewith Annual Report 24-25.10 Sep 2025 · Others / Reg. 34 (1) Annual Report
Please find attached with Notice of AGM of Gian Life Care Limited.10 Sep 2025 · AGM/EGM / AGM
Results for the Quarter ended June 30, 20252 Sep 2025 · Result / Financial Results
The Board at its meeting held on August 14, 2025 approved audited financial statements for the FY 2024-252 Sep 2025 · Result / Financial Results
Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....2 Sep 2025 · Board Meeting / Outcome of Board Meeting
Gian Life Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 and ....7 Aug 2025 · Board Meeting / Board Meeting
Gian Life Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 and ....7 Aug 2025 · Board Meeting / Board Meeting
Unaudited Standalone/ Consolidated Financial Results for the Quarter ended December 31, 2024.17 Jul 2025 · Result / Financial Results
Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....17 Jul 2025 · Board Meeting / Outcome of Board Meeting
Gian Life Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 ,inter alia, to consider and approve As per the captioned subject, ....8 Aug 2024 · Board Meeting / Board Meeting
Pls find attached herewith Certificate under Reg 74(5) of Gian Life Care Limited for the period ended June 30, 2024.20 Jul 2024 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018